Search jobs 01-Jun-2021 87% of Top 300 Pharma Companies in Europe and US have a Poor Digital Culture that Inhibits Innovation
87% of Top 300 Pharma Companies in Europe and US have a Poor Digital Culture that Inhibits Innovation
Only 13% of Companies are “Digital Leaders”, Optimising Artificial Intelligence and Machine Learning
Reading, Berkshire, 1st June 2021 – 87% of pharmaceutical manufacturing companies admit they have a poor digital culture and know it holds back digital transformation and undermines revenues, according to new research by Aspen Technology, a global leader in asset optimisation software.
Conducted among 300 senior pharmaceutical industry decision-makers in the UK, US, Germany, France, Spain and Sweden, the research reveals that just 13% of organisations fit the description of “digital culture leaders”, with confidence in adopting new technologies such as artificial intelligence (AI).